Open AccessBenefits of Conventional Chemotherapy in Progressive Disease Patients with Tyrosine-Kinase Inhibitors: A Case Report
Author(s) -
Ahmad Budi Junaidi,
Sabrina Ermayanti,
Afriani Afriani
Publication year - 2022
Publication title -
bioscientia medicina journal of biomedicine and translational research
Language(s) - English
Resource type - Journals
ISSN - 2598-0580
DOI - 10.37275/bsm.v6i14.657
Subject(s) - medicine , osimertinib , pemetrexed , carboplatin , adenocarcinoma , t790m , lung cancer , progressive disease , oncology , chemotherapy , epidermal growth factor receptor , tyrosine kinase inhibitor , pathology , gefitinib , cancer , ros1 , cisplatin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom